At the ViVE event in Los Angeles last month, health tech executives shared how their companies are putting innovative ideas into action to address the most pressing needs in healthcare, as part of the Vibe at ViVE by MedCity News.
A new EY survey found that while 86% of health executives say that digital health solutions have the potential to reduce costs, 70% said they haven’t seen a return on investment so far.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Patient safety and lack of autonomy are two of the biggest factors driving so many clinicians away from the medical field, according to a new EY report. Clinicians feel like they aren’t able to provide patients with the quality of care they need and deserve due to workforce shortages, resource constraints, and health system policies over which they have no control.
Most patients prefer in-person care to virtual, according to a recent report. This finding should drive health systems to refine their telehealth experiences — they should determine which type of visits are best-suited for the modality, and they should ensure their virtual care environments adopt a more human-centric design.
MedCity News connected with Global Health Leader at EY, Aloha McBride, to share details on the company's upcoming survey on what consumers are looking for in value-based care.
Hear from healthcare executives such as Nicholas Turos, vice president of business development with Babson Diagnostics, Marcus Perez, Altera Digital Health president, and Integra Connect COO Cory Wiegert on how they are meeting the challenges of healthcare innovation.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
About 98% of healthcare companies have a health equity strategy, but nearly 60% initiated the strategy in just the last five years and 34% created it during the Covid-19 pandemic, the EY report shows.
Wednesday, June 17, 2pm ET: The Digital Only Launch: Execute a new fit-for-purpose launch model, with MSD, Pfizer, and EY.
An EY survey of 347 physicians and healthcare executives found respondents have undertaken staff satisfaction-related projects and are planning initiatives around analytics.
With the tax reform bill that recently passed and the dramatic rate-cut for overseas cash being repatriated to 14.5 percent from 35 percent, it's no surprise that M&A deals will abound.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Despite reimbursement, regulatory, and political uncertainty, the global biotech industry held steady in 2016, according to a new report by professional services firm EY (formerly Ernst & Young).
More than 650 medical device recalls encompassing 180 million units were registered in the second half of 2016, some of the highest numbers seen this century. It's a poor departure point as a new era in product complexity begins.
Deregulation, health insurance reform, an aging senior population, and the need to improve access to care, coupled with the rise in smartphone ownership are factors fueling digital health's growth in this Asian nation.